ST-elevation myocardial infarction associated with acute ischemic stroke.
International Journal of Cardiology
|January 30, 2010
Summary
Tissue plasminogen activator therapy can improve outcomes for ischemic stroke patients, with an extended treatment window. This case highlights its potential benefits even in complex STEMI patients with stroke symptoms.
Area of Science:
- Cardiology
- Neurology
- Emergency Medicine
Background:
- Randomized trials confirm tissue plasminogen activator (tPA) improves functional outcomes in ischemic stroke.
- The therapeutic time window for tPA has been extended to 4.5 hours post-stroke onset.
- Identifying neurological contraindications for fibrinolytic therapy is crucial in ST-elevation myocardial infarction (STEMI) patients.
Observation:
- A 68-year-old male presented with heart failure, ischemic stroke, and STEMI.
- The patient received tissue plasminogen activator thrombolytic therapy.
Findings:
- The case demonstrates the successful application of tPA in a patient with concurrent STEMI and acute ischemic stroke.
- Regression of ischemic stroke symptoms was observed following tPA treatment in this STEMI patient.
Implications:
- Extending the tPA time window allows more patients to benefit from this critical treatment.
- This case underscores the importance of considering tPA in STEMI patients presenting with acute neurological deficits.
- Further investigation into tPA's role in managing combined cardiovascular and cerebrovascular events is warranted.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...